Steward Partners Investment Advisory’s Gossamer Bio GOSS Stock Holding History

Steward Partners Investment Advisory’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13	Closed	-$329	–	4751
2026 Q1	$329	Hold	13	–	–	﹤0.01%	4293
2025 Q4	$3.1K	Hold	13	–	–	﹤0.01%	3838
2025 Q3	$2.63K	Hold	13	–	–	﹤0.01%	3849
2025 Q2	$1.23K	Hold	13	–	–	﹤0.01%	3827
2025 Q1	$1.1K	Hold	13	–	–	﹤0.01%	3754
2024 Q4	$905	Buy	+13	New	+$891	﹤0.01%	3773
2021 Q2	–	Sell	-3	Closed	-$2.31K	–	7220
2021 Q1	$2.31K	Buy	+3	New	+$2.42K	﹤0.01%	3202

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Steward Partners Investment Advisory's GOSS Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 13 shares — an estimated $329 sold.

Steward Partners Investment Advisory first reported a position in GOSS in Q1 2021 and held it in 7 quarters. The position peaked at $3.1K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Steward Partners Investment Advisory reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
Steward Partners Investment Advisory sold 13 Gossamer Bio shares in Q2 2026, an estimated $329.
Steward Partners Investment Advisory first reported a position in Gossamer Bio in Q1 2021 and held it in 7 quarters.
Steward Partners Investment Advisory's Gossamer Bio position peaked at $3.1K in Q4 2025.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.